FINWIRES — Financial News

Sino Biopharma Unit Gets Trial Approval for Chronic Hepatitis B Drug in China

Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical obtained clinical trial approval for the IM-101 injection from China's National Medical Products Administration.The drug candidate has been developed for the treatment of chronic hepatitis B, according to a Thursday Hong Kong bourse filing.

HKG:1177

Treasury22d ago

The Smarter Web Repays $12 Million Convertible Instrument

The Smarter Web Co. (SWC.L) repaid a $11.7 million convertible instrument to Tobam Group two weeks in advance, according to a Thursday filing.The British web design, development and online marketing services company sold 177.8909127 Bitcoin to repay the instrument.As such, the company's Bitcoin holding reduced to 2,700 units.

$SWC.L

Research22d ago

Piper Sandler Downgrades UTZ Brands to Neutral From Overweight, Lifts Price Target to $14.25 From $10

UTZ Brands (UTZ) has an average rating of hold and mean price target of $13.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$UTZ

Research22d ago

Craig Hallum Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $32

BioLife Solutions (BLFS) has an average rating of overweight and mean price target of $31.13, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$BLFS

Research22d ago

Citigroup Downgrades Evolent Health to Neutral From Buy, Adjusts Price Target to $6.75 From $5.50

Evolent Health (EVH) has an average rating of buy and mean price target of $5.96, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$EVH

Research22d ago

BofA Securities Downgrades Rollins to Underperform From Buy, Price Target is $35

Rollins (ROL) has an average rating of overweight and mean price target of $57.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ROL

Research22d ago

TD Cowen Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $33

BioLife Solutions (BLFS) has an average rating of overweight and mean price target of $31.13, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$BLFS

Research22d ago

HC Wainwright Downgrades BioLife Solutions to Neutral From Buy, Trims Price Target to $31 From $32

BioLife Solutions (BLFS) has an average rating of overweight and mean price target of $31.13, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$BLFS

Mining & Metals22d ago

Earnings Flash (AW.TO) A&W Food Services Reports Q2 Revenue C$70.8M

$AW.TO

Research22d ago

William Blair Downgrades Pegasystems to Market Perform From Outperform

Pegasystems (PEGA) has an average rating of overweight and mean price target of $47.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PEGA

Research22d ago

KeyBanc Downgrades Pegasystems to Sector Weight From Overweight

Pegasystems (PEGA) has an average rating of overweight and mean price target of $47.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PEGA

Asia22d ago

Disco Q1 Net Profit Surges 44%; Revenue Jumps 27%

Disco (TYO:6146) posted a 44% year over year increase in net income for the fiscal first quarter to 34.2 billion yen from 23.8 billion yen a year earlier.The machinery maker's net income per share was 315.51 yen, compared with 219.23 yen a year earlier, according to a Tokyo Stock Exchange filing on Thursday.Net sales jumped 27% to 114.3 billion yen from 89.9 billion yen for the three months ended June 30.For the first half ending Sept. 30, Disco expects net income of 73.8 billion yen, net income per share of 680.39 yen and net sales of 242.8 billion yen.The company plans to pay a second quarter dividend of 171 yen per share.

TYO:6146

Mining & Metals22d ago

Serabi Gold Q2 Gold Production up 5%

Serabi Gold (SBI.TO) said Thursday that second-quarter gold production increased 5% annually to 11,007 ounces, but was lower than the 12,042 ounces production reported in the first quarter.The Brazil-focused mining company said group ore mined during the quarter was 59,094 tonnes at 6.19 grams per tonne (g/t) gold, compared with 54,965 tonnes at 7.06 g/t gold for the first quarter of 2026, the company said.Serabi Gold maintained its fiscal 2026 gold production guidance "in excess" of 53,000 ounces of gold. It produced 44,169 ounces of gold in 2025.

$SBI.TO

Research22d ago

Loop Capital Downgrades Pegasystems to Hold From Buy, Adjusts Price Target to $25 From $55

Pegasystems (PEGA) has an average rating of overweight and mean price target of $47.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PEGA

Asia22d ago

Mitsubishi Heavy Signs GCAP Collaboration Deal to Support Next-Generation Fighter Program

Mitsubishi Heavy Industries (TYO:7011) said that it signed a collaboration deal with Mitsubishi Electric (TYO:6503), MBDA UK, and MBDA Italia to support the Global Combat Air Programme, deepening cross-border cooperation on the next-generation fighter program.The Japanese industrial group said that the partnership covers cooperation on joint engineering services, expert advice, and technologies, supporting Edgewing's delivery of the core GCAP platform, according to a Thursday release.The deal, signed at the Farnborough International Airshow 2026, will focus on optimizing and digitally integrating effector systems.

TYO:6503TYO:7011

Mining & Metals22d ago

Choice Properties REIT Reports Higher Q2 FFO and Revenue

Choice Properties Real Estate Investment Trust (CHP-UN.TO) reported second-quarter funds from operations (FFO) of C$0.267 per diluted unit, compared with C$0.265 per diluted unit a year earlier.The company said the increase in FFO was primarily driven by strong same-asset net operating income growth.Rental revenue for the three months ended June 30, 2026, increased to C$361.3 million, compared with C$350.8 million, a year-ago.The company continues to forecast annual FFO per diluted unit in a range of about C$1.08 to C$1.10, and stable occupancy across the portfolio, resulting in about 2%-3% year-over-year growth in same-asset NOI, on a cash basis.Shares of the company closed up 0.1% to C$16.3 on Wednesday on the Toronto Stock Exchange.

$CHP-UN.TO

Research22d ago

Jefferies Initiates StoneCo at Hold With $12.60 Price Target

StoneCo (STNE) has an average rating of overweight and mean price target of $15.74, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$STNE

Research22d ago

Guggenheim Initiates Guidewire Software at Buy

Guidewire Software (GWRE) has an average rating of buy and mean price target of $196.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$GWRE

Research22d ago

Stephens Initiates Alphatec Holdings at Overweight With $15 Price Target

Alphatec Holdings (ATEC) has an average rating of buy and mean price target of $15.92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ATEC

Research22d ago

Stephens Initiates iRhythm Technologies at Overweight With $160 Price Target

iRhythm Technologies (IRTC) has an average rating of buy and mean price target of $177.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$IRTC

Financial News · Live Terminal

Sino Biopharma Unit Gets Trial Approval for Chronic Hepatitis B Drug in China

The Smarter Web Repays $12 Million Convertible Instrument

Piper Sandler Downgrades UTZ Brands to Neutral From Overweight, Lifts Price Target to $14.25 From $10

Craig Hallum Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $32

Citigroup Downgrades Evolent Health to Neutral From Buy, Adjusts Price Target to $6.75 From $5.50

BofA Securities Downgrades Rollins to Underperform From Buy, Price Target is $35

TD Cowen Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $33

HC Wainwright Downgrades BioLife Solutions to Neutral From Buy, Trims Price Target to $31 From $32

Earnings Flash (AW.TO) A&W Food Services Reports Q2 Revenue C$70.8M

William Blair Downgrades Pegasystems to Market Perform From Outperform

KeyBanc Downgrades Pegasystems to Sector Weight From Overweight

Disco Q1 Net Profit Surges 44%; Revenue Jumps 27%

Serabi Gold Q2 Gold Production up 5%

Loop Capital Downgrades Pegasystems to Hold From Buy, Adjusts Price Target to $25 From $55

Mitsubishi Heavy Signs GCAP Collaboration Deal to Support Next-Generation Fighter Program

Choice Properties REIT Reports Higher Q2 FFO and Revenue

Jefferies Initiates StoneCo at Hold With $12.60 Price Target

Guggenheim Initiates Guidewire Software at Buy

Stephens Initiates Alphatec Holdings at Overweight With $15 Price Target

Stephens Initiates iRhythm Technologies at Overweight With $160 Price Target

Sino Biopharma Unit Gets Trial Approval for Chronic Hepatitis B Drug in China

The Smarter Web Repays $12 Million Convertible Instrument

Piper Sandler Downgrades UTZ Brands to Neutral From Overweight, Lifts Price Target to $14.25 From $10

Craig Hallum Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $32

Citigroup Downgrades Evolent Health to Neutral From Buy, Adjusts Price Target to $6.75 From $5.50

BofA Securities Downgrades Rollins to Underperform From Buy, Price Target is $35

TD Cowen Downgrades BioLife Solutions to Hold From Buy, Trims Price Target to $31 From $33

HC Wainwright Downgrades BioLife Solutions to Neutral From Buy, Trims Price Target to $31 From $32

Earnings Flash (AW.TO) A&W Food Services Reports Q2 Revenue C$70.8M

William Blair Downgrades Pegasystems to Market Perform From Outperform

KeyBanc Downgrades Pegasystems to Sector Weight From Overweight

Disco Q1 Net Profit Surges 44%; Revenue Jumps 27%

Serabi Gold Q2 Gold Production up 5%

Loop Capital Downgrades Pegasystems to Hold From Buy, Adjusts Price Target to $25 From $55

Mitsubishi Heavy Signs GCAP Collaboration Deal to Support Next-Generation Fighter Program

Choice Properties REIT Reports Higher Q2 FFO and Revenue

Jefferies Initiates StoneCo at Hold With $12.60 Price Target

Guggenheim Initiates Guidewire Software at Buy

Stephens Initiates Alphatec Holdings at Overweight With $15 Price Target

Stephens Initiates iRhythm Technologies at Overweight With $160 Price Target